In our study, we discovered that PI16 plays a vital role in suppressing the development of tumours and the progression of metastasis in BLCA by inhibiting the activity of NF-κB through ANXA1-dependent ubiquitination of NEMO. The gene discussed is ANXA1; the disease is bladder transitional cell carcinoma.